- Research Interests:
Clinical trial design and development for novel therapeutics and immunotherapy for the treatment of lung cancer.
- Clinical Practice:
- Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Immunotherapy (Biological Therapy), Small Cell Lung Cancer, Thymoma and Thymic Carcinoma
Hem/Onc Fellowship Director
- Assistant Professor
Richard D. Hall, MD, MS is a native of Texas, where he attended Texas A&M University and completed medical school at the University of Texas Southwestern in Dallas. He completed his internal medicine residency at the University of Virginia in 2010 and went on to serve as a chief resident at UVA in 2010-2011. Dr. Hall completed his fellowship training at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, in 2014. As a fellow, he attended the American Association for Cancer Research Molecular Biology Workshop in Snowmass, CO, and completed a Master of Science degree in clinical and translational research at the University of South Florida.
Dr. Hall joined the UVA School of Medicine faculty and UVA Cancer Center in 2014. He specializes in the treatment of thoracic malignancies, including non-small-cell lung cancer, small-cell lung cancer, thymic malignancies and mesothelioma. His primary research focus is the application of novel therapeutics, including immunotherapy, antibody drug conjugates, tyrosine kinase inhibitors and combination therapies for the treatment of lung cancer. Dr. Hall has been the UVA principal investigator on multiple lung cancer clinical trials since joining the faculty. In addition to his clinical work, Dr. Hall is involved in the educational leadership of the internal medicine residency program and became the hematology/oncology fellowship program director in August 2017.
- Internal Medicine, University of Virginia
- Hematology and Oncology, University of South Florida